No records
|
535 |
Zeziulin O., Mollan K.R., Shook-Sa B.E., Hanscom B., Lancaster K.E., Dumchev K., Go V.F., Chu V.A., Kiriazova T., Syarif Z., Dvoryak S., Reifeis S.A., Hamilton E., Sarasvita R., Rose S., Richardson P., Clarke W., Latkin C.A., Metzger D.S., Hoffman I.F., Miller W.C. |
55759565100;26659057900;55990940100;6603650318;55503210000;8923601900;7102536801;57195576444;55757875500;57216745876;15051444200;57193208279;56450237600;50462352200;12544917400;57203639655;16400885000;7006006751;35944632400;7006682600;57217026028; |
Depressive symptoms and use of HIV care and medication-assisted treatment among people with HIV who inject drugs |
2021 |
AIDS |
35 |
3 |
|
495 |
501 |
|
1 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85101895969&doi=10.1097%2fQAD.0000000000002774&partnerID=40&md5=dc8da3aef65727a23f50b2418240ffe3 |
Ukrainian Institute on Public Health Policy, Kyiv, Ukraine; School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States; Gillings School of Global Public Health, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States; Statistical Center for HIV/AIDS Research and Prevention (SCHARP), Fred Hutchinson Cancer Research Center, Seattle, WA, United States; College of Public Health, The Ohio State University, Columbus, OH, United States; UNC Vietnam, Ho Chi Minh City, Viet Nam; Abhipraya Foundation, Department Psychiatry, Faculty of Medicine, University of Indonesia, Depok, Indonesia; Family Health International (FHI 360), Durham, NC, United States; Indonesia National Narcotics Board, Abhipraya Foundation, East Jakarta, Indonesia; Johns Hopkins University, Baltimore, MD, United States; University of Pennsylvania, Philadelphia, PA, United States |
Zeziulin, O., Ukrainian Institute on Public Health Policy, Kyiv, Ukraine; Mollan, K.R., School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States, Gillings School of Global Public Health, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States; Shook-Sa, B.E., Gillings School of Global Public Health, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States; Hanscom, B., Statistical Center for HIV/AIDS Research and Prevention (SCHARP), Fred Hutchinson Cancer Research Center, Seattle, WA, United States; Lancaster, K.E., College of Public Health, The Ohio State University, Columbus, OH, United States; Dumchev, K., Ukrainian Institute on Public Health Policy, Kyiv, Ukraine; Go, V.F., Gillings School of Global Public Health, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States; Chu, V.A., UNC Vietnam, Ho Chi Minh City, Viet Nam; Kiriazova, T., Ukrainian Institute on Public Health Policy, Kyiv, Ukraine; Syarif, Z., Abhipraya Foundation, Department Psychiatry, Faculty of Medicine, University of Indonesia, Depok, Indonesia; Dvoryak, S., Ukrainian Institute on Public Health Policy, Kyiv, Ukraine; Reifeis, S.A., Gillings School of Global Public Health, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States; Hamilton, E., Family Health International (FHI 360), Durham, NC, United States; Sarasvita, R., Indonesia National Narcotics Board, Abhipraya Foundation, East Jakarta, Indonesia; Rose, S., Family Health International (FHI 360), Durham, NC, United States; Richardson, P., Johns Hopkins University, Baltimore, MD, United States; Clarke, W., Johns Hopkins University, Baltimore, MD, United States; Latkin, C.A., University of Pennsylvania, Philadelphia, PA, United States; Metzger, D.S., University of Pennsylvania, Philadelphia, PA, United States; Hoffman, I.F., School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States; Miller, W.C., College of Public Health, The Ohio State University, Columbus, OH, United States |
Objective: Vietnam, Indonesia, and Ukraine have major burdens of IDU and HIV. We estimated the prevalence of depressive symptoms at baseline among people living with HIV who inject drugs, evaluated associations between depression at baseline and 12-month HIV care outcomes and medication-assisted treatment (MAT), and evaluated the study intervention effect by baseline depression subgroups. Design: HPTN 074 was a randomized study. The study intervention included psychosocial counseling, systems navigation, and antiretroviral treatment (ART) at any CD4þ cell count. Methods: Moderate-to-severe depression was defined as a Patient Health Questionnaire-9 score of 10 or above. ART and MAT were self-reported. Eligibility criteria were: 18–60 years of age, active IDU, and viral load of at least 1000 copies/ml. Adjusted probability differences (aPD) were estimated using inverse-probability weighting. Results: A total of 502 participants enrolled from April 2015 to June 2016. Median age was 35 years; 85% identified as men. Prevalence of baseline moderate-to-severe depression was 14% in Vietnam, 14% in Indonesia, and 56% in Ukraine. No evident associations were detected between baseline depression and ART, viral suppression, or MAT at 12-month follow-up. The study intervention improved the proportions of people who inject drugs achieving 12-month viral suppression in both the depressed [intervention 44%; standard of care 24%; estimated aPD ¼ 25% (95% confidence interval: 4.0%, 45%)] and nondepressed subgroups [intervention 38%; standard of care 24%; aPD ¼ 13% (95% confidence interval: 2.0%, 25%)]. Conclusion: High levels of depressive symptoms were common among people living with HIV who inject drugs in Ukraine but were less common in Vietnam and Indonesia. The study intervention was effective among participants with or without baseline depression symptoms. Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved. |
Antiretroviral therapy; Depression; Drug users; HIV; Opioid medication assisted treatment; Viral load |
antiretrovirus agent; CD4 antigen; drug; adult; antiretroviral therapy; Article; CD4 lymphocyte count; cohort analysis; controlled study; depression; disease burden; disease severity; female; follow up; health care quality; human; Human immunodeficiency virus infected patient; Human immunodeficiency virus infection; Indonesia; injection drug user; major clinical study; male; mortality; mortality rate; nonhuman; outcome assessment; patient care; patient counseling; Patient Health Questionnaire 9; prevalence; psychosocial care; randomized controlled trial; Ukraine; Viet Nam; virus inhibition; virus load; complication; depression; Adult; Depression; HIV Infections; Humans; Indonesia; Male; Pharmaceutical Preparations; Ukraine; Vietnam; Viral Load |
Lippincott Williams and Wilkins |
02699370 |
|
33252489 |
Article |
Q1 |
2195 |
1133 |
|
|
550 |
Patandung R., Prapiska F.F., Kadar D.D. |
57200945097;57208879216;57217832474; |
Open pyelolithotomy in an ectopic kidney: A case report |
2021 |
Urology Case Reports |
35 |
|
101528 |
|
|
|
1 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85097735075&doi=10.1016%2fj.eucr.2020.101528&partnerID=40&md5=95fd95b0363fa0eb89c9009f10649d8d |
Department of Urology, Faculty of Medicine Universitas Indonesia, Haji Adam Malik Hospital, Medan, Indonesia; Division of Urology, Department of Surgery, Faculty of Medicine Universitas Sumatera Utara, Haji Adam Malik Hospital, Medan, Indonesia |
Patandung, R., Department of Urology, Faculty of Medicine Universitas Indonesia, Haji Adam Malik Hospital, Medan, Indonesia; Prapiska, F.F., Division of Urology, Department of Surgery, Faculty of Medicine Universitas Sumatera Utara, Haji Adam Malik Hospital, Medan, Indonesia; Kadar, D.D., Division of Urology, Department of Surgery, Faculty of Medicine Universitas Sumatera Utara, Haji Adam Malik Hospital, Medan, Indonesia |
Renal ectopia with stone is a rare case with no specific reported incidence rate. The treatment of kidney stone in ectopic kidneys poses a challenge to urologists. A 48-year-old male presenting with colicky pain on the right flank since one year ago. CT urography revealed an right-crossed renal ectopia and hyperdense lesions (25 × 20 mm and 10 × 10 mm) in the ureteropelvic junction of the right kidney. Under general anesthesia, we performed open pyelolithotomy for the patient and removed two stones completely. Open surgery could be the choice for patients with complex stone burden and associated renal anomalies such as ectopic kidney. © 2020 |
Ectopic kidney; Open pyelolithotomy; Renal stones |
polyglactin; abdominal drainage; abdominal mass; abdominal radiography; adult; Article; case report; clinical article; computer assisted tomography; ectopic kidney; gerota fascia; human; kidney function test; kidney pelvis; male; middle aged; nephrolithiasis; open surgery; physical examination; pyelolithotomy; retroperitoneum; ureteropelvic junction; urinalysis; urography; urologist |
Elsevier Inc. |
22144420 |
|
|
Article |
Q3 |
245 |
16962 |
|
|
No records
|
51 |
Viswanathan S., Hiew F.L., Siritho S., Apiwattanakul M., Tan K., Quek A.M.L., Estiasari R., Remli R., Bhaskar S., Islam B.M., Aye S.M.M., Ohnmar O., Umapathi T., Keosodsay S.S., Hoang N.T.T., Yeo T., Pasco P.M. |
56372225400;56520422700;15519966800;57195288799;37032197900;13605538000;55240204000;6504090091;57226417398;57194464797;55644071900;57201460031;6602092493;57201460833;57310352700;57310352800;6506559205; |
Impact of Covid-19 on the therapeutic plasma exchange service within the South East Asian region: Consensus recommendations and global perspectives |
2021 |
Journal of Clinical Apheresis |
36 |
6 |
|
849 |
863 |
|
|
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85117763064&doi=10.1002%2fjca.21937&partnerID=40&md5=3fb4e2326e829716a437226b18f33390 |
Department of Neurology, Kuala Lumpur Hospital, Kuala Lumpur, Malaysia; Department of Neurology, Bumrungrad International Hospital and Siriraj Hospital, Mahidol University, Bangkok, Thailand; Department of Neurology, Neurological Institute of Thailand, Bangkok, Thailand; Department of Neurology, National Neuroscience Institute, Singapore; Division of Neurology, Department of Medicine, National University Health System, Singapore; Department of Neurology, Faculty of Medicine Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Department of Neurology, National University of Malaysia, Kuala Lumpur, Malaysia; Department of Medicine, Universiti Teknologi MARA, Sg Buloh, Selangor, Malaysia; Department of Laboratory Sciences and Services Division, The International Center for Diarrhoeal Disease Research, Dhaka, Bangladesh; Department of Neurology, Aryu International Hospital, Yangon, Myanmar; Department of Neurology, Yangon General Hospital, Yangon, Myanmar; Department of Neurology, Laos General Hospital, Vientiane, Laos; Department of Neurology, Military Hospital 175, Ho Chi Minh City, Viet Nam; Department of Neurosciences, Philippine General Hospital, Manila, Philippines |
Viswanathan, S., Department of Neurology, Kuala Lumpur Hospital, Kuala Lumpur, Malaysia; Hiew, F.L., Department of Neurology, Kuala Lumpur Hospital, Kuala Lumpur, Malaysia; Siritho, S., Department of Neurology, Bumrungrad International Hospital and Siriraj Hospital, Mahidol University, Bangkok, Thailand; Apiwattanakul, M., Department of Neurology, Neurological Institute of Thailand, Bangkok, Thailand; Tan, K., Department of Neurology, National Neuroscience Institute, Singapore; Quek, A.M.L., Division of Neurology, Department of Medicine, National University Health System, Singapore; Estiasari, R., Department of Neurology, Faculty of Medicine Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Remli, R., Department of Neurology, National University of Malaysia, Kuala Lumpur, Malaysia; Bhaskar, S., Department of Medicine, Universiti Teknologi MARA, Sg Buloh, Selangor, Malaysia; Islam, B.M., Department of Laboratory Sciences and Services Division, The International Center for Diarrhoeal Disease Research, Dhaka, Bangladesh; Aye, S.M.M., Department of Neurology, Aryu International Hospital, Yangon, Myanmar; Ohnmar, O., Department of Neurology, Yangon General Hospital, Yangon, Myanmar; Umapathi, T., Department of Neurology, National Neuroscience Institute, Singapore; Keosodsay, S.S., Department of Neurology, Laos General Hospital, Vientiane, Laos; Hoang, N.T.T., Department of Neurology, Military Hospital 175, Ho Chi Minh City, Viet Nam; Yeo, T., Department of Neurology, National Neuroscience Institute, Singapore; Pasco, P.M., Department of Neurosciences, Philippine General Hospital, Manila, Philippines |
Introduction: Therapeutic plasma exchange (TPE) for neuroimmunological disorders has played an increasingly important role within the Southeast Asian (SEA) region. The South East Asian Therapeutic Plasma exchange Consortium (SEATPEC) was formed in 2018 to promote education and research on TPE within the region. The advent of the Covid-19 pandemic has produced challenges for the development and expansion of this service. Methodology: A qualitative and semi-quantitative questionnaire-based survey was conducted by SEATPEC member countries from January to June 2020 (Phase 1) and then from July 2020 to January 2021 in (Phase 2) to assess the impact of Covid-19 on regional TPE. Objectives: The study's main objectives were to explore the challenges experienced and adaptations/adjustments taken by SEATPEC countries in order to continue safe and efficient TPE during the Covid-19 pandemic. Results: The pandemic was found to disrupt the delivery of TPE services in all SEATPEC countries. Contributing factors were multifactorial due to overstretched medical services, staff shortages, quarantines and redeployments, fear of acquiring Covid-19, movement restriction orders, and patient's psychological fear of attending hospitals/testing for Covid-19. All SEATPEC countries practiced careful stratification of cases for TPE (electives vs emergencies, Covid-19 vs non-Covid-19 cases). SEATPEC countries had to modify TPE treatment protocols to include careful preprocedure screening of patient's for Covid-19, use of personal protective equipment (PPE) and post-TPE sanitization of machines and TPE suites. Conclusion: Based on the responses of the survey, SEATPEC countries produced a consensus statement with five recommendations for safe and effective TPE within the region. © 2021 Wiley Periodicals LLC. |
Covid-19; impact; South East Asia; therapeutic plasma exchange |
complication; consensus; epidemiology; human; neurologic disease; neurologist; pandemic; plasma exchange; procedures; questionnaire; Southeast Asia; Asia, Southeastern; Consensus; COVID-19; Humans; Nervous System Diseases; Neurologists; Pandemics; Plasma Exchange; SARS-CoV-2; Surveys and Questionnaires |
John Wiley and Sons Inc |
07332459 |
|
34694652 |
Article |
Q2 |
697 |
7146 |
|
|
112 |
Ong J., Ong A.M.L., Ong S., Xin X., Lee Y.Y., Pausawasdi N., De Lusong M.A., Makmun D., Chong V.H., Ho S.H., Lim W., Ong D., Dan Y.Y., Khor C. |
57193716100;36942342000;35741447900;57326122500;56191149300;6602327609;23767987600;16638046900;54790563600;50561284200;57194415809;56013316700;8699022400;8549610200; |
The impact of the coronavirus disease 2019 pandemic on gastroenterologists in Southeast Asia: A mixed-methods study |
2021 |
Journal of Gastroenterology and Hepatology (Australia) |
36 |
11 |
|
3056 |
3068 |
|
1 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85112680822&doi=10.1111%2fjgh.15594&partnerID=40&md5=3c1bb0505aa3a502aa7cea4abadd518a |
Department of Medicine, National University of Singapore, Singapore; Department of Engineering, University of Cambridge, Cambridge, United Kingdom; Department of Gastroenterology and Hepatology, Singapore General Hospital, Singapore; Duke-NUS Medical School, Singapore; Department of Surgical Intensive Care, Singapore General Hospital, Singapore; Department of Anaesthesiology, Sengkang General Hospital, Singapore; Health Services Research Unit, Singapore General Hospital, Singapore; School of Medical Sciences, Universiti Sains Malaysia, Kota Bharu, Malaysia; GI Function and Motility Unit, Hospital Universiti Sains Malaysia, Kota Bharu, Malaysia; Division of Gastroenterology, Department of Medicine, Mahidol University Faculty of Medicine at Siriraj Hospital, Bangkok, Thailand; Section of Advanced Endoscopy, Division of Gastroenterology, Department of Medicine, Philippine General Hospital, Manila, Philippines; Faculty of Medicine, Division of Gastroenterology, Department of Internal Medicine, Cipto Mangunkusumo National General Hospital, Universitas Indonesia, Jakarta, Indonesia; Gastroenterology Unit, Department of Medicine, RIPAS Hospital, Bandar Seri Begawan, Brunei Darussalam; Institute of Health Sciences, PAPRSB Universiti of Brunei Darussalam, Bandar Seri Begawan, Brunei Darussalam; Department of Medicine, University of Malaya, Kuala Lumpur, Malaysia; Department of Anaesthesiology, Singapore General Hospital, Singapore; Department of Medicine, Division of Gastroenterology and Hepatology, National University Hospital, Singapore |
Ong, J., Department of Medicine, National University of Singapore, Singapore, Department of Engineering, University of Cambridge, Cambridge, United Kingdom; Ong, A.M.L., Department of Gastroenterology and Hepatology, Singapore General Hospital, Singapore, Duke-NUS Medical School, Singapore; Ong, S., Department of Surgical Intensive Care, Singapore General Hospital, Singapore, Department of Anaesthesiology, Sengkang General Hospital, Singapore; Xin, X., Health Services Research Unit, Singapore General Hospital, Singapore; Lee, Y.Y., School of Medical Sciences, Universiti Sains Malaysia, Kota Bharu, Malaysia, GI Function and Motility Unit, Hospital Universiti Sains Malaysia, Kota Bharu, Malaysia; Pausawasdi, N., Division of Gastroenterology, Department of Medicine, Mahidol University Faculty of Medicine at Siriraj Hospital, Bangkok, Thailand; De Lusong, M.A., Section of Advanced Endoscopy, Division of Gastroenterology, Department of Medicine, Philippine General Hospital, Manila, Philippines; Makmun, D., Faculty of Medicine, Division of Gastroenterology, Department of Internal Medicine, Cipto Mangunkusumo National General Hospital, Universitas Indonesia, Jakarta, Indonesia; Chong, V.H., Gastroenterology Unit, Department of Medicine, RIPAS Hospital, Bandar Seri Begawan, Brunei Darussalam, Institute of Health Sciences, PAPRSB Universiti of Brunei Darussalam, Bandar Seri Begawan, Brunei Darussalam; Ho, S.H., Department of Medicine, University of Malaya, Kuala Lumpur, Malaysia; Lim, W., Department of Anaesthesiology, Sengkang General Hospital, Singapore, Department of Anaesthesiology, Singapore General Hospital, Singapore; Ong, D., Department of Medicine, Division of Gastroenterology and Hepatology, National University Hospital, Singapore; Dan, Y.Y., Department of Medicine, National University of Singapore, Singapore, Department of Medicine, Division of Gastroenterology and Hepatology, National University Hospital, Singapore; Khor, C., Department of Gastroenterology and Hepatology, Singapore General Hospital, Singapore, Duke-NUS Medical School, Singapore |
Background and Aim: The coronavirus disease 2019 pandemic has impacted gastroenterology practices worldwide; however, its protracted effects within Southeast Asia were unknown. The primary aim of the study was to determine the impact of the pandemic on clinical demands including burnout among gastroenterologists within the region. The secondary aim was to identify risk factors for burnout and determine regional stressors. Methods: This was a mixed-methods study. Gastroenterologists were surveyed electronically between September 1 and December 7, 2020, via gastroenterology and endoscopy societies of Brunei, Indonesia, Malaysia, Philippines, Singapore, and Thailand. Quantitative and qualitative data were collected. The 22-item Maslach Burnout Inventory-Human Services Survey (MBI-HSS) was used to detect burnout. Quantitative data were non-parametric; non-parametric methods were used for statistical comparisons. Logistic regression was used to determine risk factors for burnout. Content analysis method was used to analyze qualitative data. Ethical approval was obtained. Results: A total of 73.0% reported that they were still significantly affected by the pandemic. Of these, 40.5% reported increased workload and 59.5% decreased workload. Statistically significant differences in weekly working hours, endoscopy, and inpatient volumes were present. No differences were observed in outpatient volumes, likely because of telemedicine. Burnout was common; however, 50.1% of gastroenterologists were unaware of or did not have access to mental health support. This, as well as depression, being a trainee, and public sector work, increased burnout risk significantly. Conclusion: The effects of the pandemic are multifaceted, and burnout is common among Southeast Asian gastroenterologists. Safeguards for mental health are suboptimal, and improvements are urgently needed. © 2021 The Authors. Journal of Gastroenterology and Hepatology published by Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd. |
burnout; COVID-19; gastroenterologists; gastroenterology; pandemic |
adult; Article; Brunei Darussalam; content analysis; controlled study; coronavirus disease 2019; data collection method; depression; endoscopy; female; gastroenterologist; hospital patient; human; Indonesia; job stress; logistic regression analysis; major clinical study; Malaysia; male; Maslach Burnout Inventory-Human Services Survey; mental health; multicenter study; nonparametric test; pandemic; Philippines; professional burnout; public sector; qualitative research; quantitative analysis; risk factor; Singapore; Southeast Asia; telemedicine; Thailand; workload; burnout; epidemiology; gastroenterologist; middle aged; pandemic; psychology; questionnaire; Adult; Asia, Southeastern; Burnout, Professional; COVID-19; Female; Gastroenterologists; Humans; Male; Middle Aged; Pandemics; SARS-CoV-2 |
John Wiley and Sons Inc |
08159319 |
|
34159640 |
Article |
Q1 |
1214 |
3242 |
|
|
266 |
Akada J., Tshibangu-Kabamba E., Tuan V.P., Kurogi S., Matsuo Y., Ansari S., Doohan D., Phuc B.H., Subsomwong P., Waskito L.A., Binh T.T., Nguyen L.T., Khien V.V., Dung H.D.Q., Miftahussurur M., Syam A.F., Tshering L., Vilaichone R.-K., Mahachai V., Ratanachu-ek T., Shrestha P.K., Yee T.T., Htet K., Aftab H., Matsuhisa T., Uchida T., Okimoto T., Mizukami K., Kodama M., Murakami K., Takahashi N., Yamaoka Y. |
6506986959;57218760439;57195367045;57195277760;55567953900;55523204000;57204644036;57222165127;57113712700;57192177367;55415987700;35285702000;6507745643;56681908900;56323903000;8443384400;57211294242;6701788898;7003739875;6507122700;8099897200;57211455497;57241639000;55359226800;7005493709;35286123100;7005300232;7005239531;35285903900;57214336895;7403938865;55183784100; |
Serum Helicobacter pylori antibody reactivity in seven Asian countries using an automated latex aggregation turbidity assay |
2021 |
Journal of Gastroenterology and Hepatology (Australia) |
36 |
8 |
|
2198 |
2209 |
|
2 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85102320750&doi=10.1111%2fjgh.15467&partnerID=40&md5=71760e350adacfbf3a65094e953e8182 |
Department of Environmental and Preventive Medicine, Faculty of Medicine, Oita University, Yufu, Japan; Clinical Laboratory Center, Oita University Hospital, Yufu, Japan; Department of Endoscopy, Cho Ray Hospital, Ho Chi Minh City, Viet Nam; Department of Hepatogastroenterology, 108 Military Central Hospital, Hanoi, Viet Nam; Institute of Tropical Disease, Airlangga University, Surabaya, Indonesia; Gastroentero-Hepatology Division, Department of Internal Medicine, Faculty of Medicine-Dr. Soetomo Teaching Hospital, Airlangga University, Surabaya, Indonesia; Division of Gastroenterology, Department of Intestinal Medicine, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia; Department of Surgery, Jigme Dorji Wangchuck National Referral Hospital, Thimphu, Bhutan; Gastroenterology Unit, Digestive Diseases Research Center, Thammasat University Hospital, Khlong Luang, Thailand; Department of Medicine, Chulabhorn International College of Medicine, Thammasat University Hospital, Khlong Luang, Thailand; GI and Liver Center, Bangkok Medical Center, Bangkok, Thailand; Department of Surgery, Rajavithi Hospital, Bangkok, Thailand; Department of Gastroenterology, Maharajgunj Medical Campus, Tribhuvan University Teaching Hospital, Kathmandu, Nepal; Department of GI and HBP Surgery, No (2) Defense Service General Hospital, Nay Pyi Taw, Myanmar; Department of GI and HBP Surgery, No (1) Defense Service General Hospital, Mingaladon, Myanmar; Department of Gastroenterology, Dhaka Medical Collage and Hospital, Dhaka, Bangladesh; Department of Gastroenterology, Tama-Nagayama University Hospital, Nippon Medical School, Tama, Japan; Department of Molecular Pathology, Faculty of Medicine, Oita University, Yufu, Japan; Department of Gastroenterology, Faculty of Medicine, Oita University, Yufu, Japan; Faculty of Welfare and Health Science, Oita University, Yufu, Japan; Global Oita Medical Advanced Research Center for Health, Oita University, Yufu, Japan; Department of Medicine, Gastroenterology and Hepatology Section, Baylor College of Medicine, Houston, TX, United States |
Akada, J., Department of Environmental and Preventive Medicine, Faculty of Medicine, Oita University, Yufu, Japan; Tshibangu-Kabamba, E., Department of Environmental and Preventive Medicine, Faculty of Medicine, Oita University, Yufu, Japan; Tuan, V.P., Department of Environmental and Preventive Medicine, Faculty of Medicine, Oita University, Yufu, Japan, Department of Endoscopy, Cho Ray Hospital, Ho Chi Minh City, Viet Nam; Kurogi, S., Clinical Laboratory Center, Oita University Hospital, Yufu, Japan, Department of Molecular Pathology, Faculty of Medicine, Oita University, Yufu, Japan; Matsuo, Y., Department of Environmental and Preventive Medicine, Faculty of Medicine, Oita University, Yufu, Japan; Ansari, S., Department of Environmental and Preventive Medicine, Faculty of Medicine, Oita University, Yufu, Japan; Doohan, D., Department of Environmental and Preventive Medicine, Faculty of Medicine, Oita University, Yufu, Japan, Institute of Tropical Disease, Airlangga University, Surabaya, Indonesia; Phuc, B.H., Department of Environmental and Preventive Medicine, Faculty of Medicine, Oita University, Yufu, Japan; Subsomwong, P., Department of Environmental and Preventive Medicine, Faculty of Medicine, Oita University, Yufu, Japan; Waskito, L.A., Department of Environmental and Preventive Medicine, Faculty of Medicine, Oita University, Yufu, Japan, Institute of Tropical Disease, Airlangga University, Surabaya, Indonesia; Binh, T.T., Department of Endoscopy, Cho Ray Hospital, Ho Chi Minh City, Viet Nam; Nguyen, L.T., Department of Hepatogastroenterology, 108 Military Central Hospital, Hanoi, Viet Nam; Khien, V.V., Department of Hepatogastroenterology, 108 Military Central Hospital, Hanoi, Viet Nam; Dung, H.D.Q., Department of Endoscopy, Cho Ray Hospital, Ho Chi Minh City, Viet Nam; Miftahussurur, M., Institute of Tropical Disease, Airlangga University, Surabaya, Indonesia, Gastroentero-Hepatology Division, Department of Internal Medicine, Faculty of Medicine-Dr. Soetomo Teaching Hospital, Airlangga University, Surabaya, Indonesia; Syam, A.F., Division of Gastroenterology, Department of Intestinal Medicine, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia; Tshering, L., Department of Surgery, Jigme Dorji Wangchuck National Referral Hospital, Thimphu, Bhutan; Vilaichone, R.-K., Gastroenterology Unit, Digestive Diseases Research Center, Thammasat University Hospital, Khlong Luang, Thailand, Department of Medicine, Chulabhorn International College of Medicine, Thammasat University Hospital, Khlong Luang, Thailand; Mahachai, V., GI and Liver Center, Bangkok Medical Center, Bangkok, Thailand; Ratanachu-ek, T., Department of Surgery, Rajavithi Hospital, Bangkok, Thailand; Shrestha, P.K., Department of Gastroenterology, Maharajgunj Medical Campus, Tribhuvan University Teaching Hospital, Kathmandu, Nepal; Yee, T.T., Department of GI and HBP Surgery, No (2) Defense Service General Hospital, Nay Pyi Taw, Myanmar; Htet, K., Department of GI and HBP Surgery, No (1) Defense Service General Hospital, Mingaladon, Myanmar; Aftab, H., Department of Gastroenterology, Dhaka Medical Collage and Hospital, Dhaka, Bangladesh; Matsuhisa, T., Department of Gastroenterology, Tama-Nagayama University Hospital, Nippon Medical School, Tama, Japan; Uchida, T., Department of Molecular Pathology, Faculty of Medicine, Oita University, Yufu, Japan; Okimoto, T., Department of Gastroenterology, Faculty of Medicine, Oita University, Yufu, Japan; Mizukami, K., Department of Gastroenterology, Faculty of Medicine, Oita University, Yufu, Japan; Kodama, M., Department of Gastroenterology, Faculty of Medicine, Oita University, Yufu, Japan, Faculty of Welfare and Health Science, Oita University, Yufu, Japan; Murakami, K., Department of Gastroenterology, Faculty of Medicine, Oita University, Yufu, Japan; Takahashi, N., Clinical Laboratory Center, Oita University Hospital, Yufu, Japan; Yamaoka, Y., Department of Environmental and Preventive Medicine, Faculty of Medicine, Oita University, Yufu, Japan, Global Oita Medical Advanced Research Center for Health, Oita University, Yufu, Japan, Department of Medicine, Gastroenterology and Hepatology Section, Baylor College of Medicine, Houston, TX, United States |
Background and Aim: To determine the application range of diagnostic kits utilizing anti-Helicobacter pylori antibody, we tested a newly developed latex aggregation turbidity assay (latex) and a conventional enzyme-linked immunosorbent assay (E-plate), both containing Japanese H. pylori protein lysates as antigens, using sera from seven Asian countries. Methods: Serum samples (1797) were obtained, and standard H. pylori infection status and atrophy status were determined by culture and histology (immunohistochemistry) using gastric biopsy samples from the same individuals. The two tests (enzyme-linked immunosorbent assay and latex) were applied, and receiver operating characteristics analysis was performed. Results: Area under the curve (AUC) from the receiver operating characteristic of E-plate and latex curves were almost the same and the highest in Vietnam. The latex AUC was slightly lower than the E-plate AUC in other countries, and the difference became statistically significant in Myanmar and then Bangladesh as the lowest. To consider past infection cases, atrophy was additionally evaluated. Most of the AUCs decreased using this atrophy-evaluated status; however, the difference between the two kits was not significant in each country, but the latex AUC was better using all samples. Practical cut-off values were 3.0 U/mL in the E-test and 3.5 U/mL in the latex test, to avoid missing gastric cancer patients to the greatest extent possible. Conclusions: The kits were applicable in all countries, but new kits using regional H. pylori strains are recommended for Myanmar and Bangladesh. Use of a cut-off value lower than the best cut-off value is essential for screening gastric cancer patients. © 2021 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd |
Asia; ELISA; Helicobacter pylori; Latex aggregation turbidity assay; Serum antibody |
antigen; bacterium antibody; immunoglobulin G; protein hydrolysate; bacterium antibody; adult; antibody blood level; Article; Asia; bacterial strain; bacterium culture; Bangladesh; Bhutan; cancer patient; cancer screening; controlled study; diagnostic accuracy; diagnostic test; evaluation study; female; Helicobacter infection; Helicobacter pylori; histopathology; human; human tissue; immunohistochemistry; Indonesia; infection rate; Japan; latex aggregation turbidity assay; major clinical study; male; marginal zone lymphoma; middle aged; Myanmar; Nepal; nonhuman; plate ELISA; predictive value; receiver operating characteristic; reference value; sensitivity and specificity; serum; statistical significance; stomach atrophy; stomach biopsy; stomach cancer; Viet Nam; aged; atrophy; biopsy; bloo |
John Wiley and Sons Inc |
08159319 |
|
33609333 |
Article |
Q1 |
1214 |
3242 |
|
|
267 |
Quek S.X.Z., Loo E.X.L., Demutska A., Chua C.E., Kew G.S., Wong S., Lau H.X., Low E.X.S., Loh T.L., Lung O.S., Hung E.C.W., Rahman M.M., Ghoshal U.C., Wong S.H., Cheung C.K.Y., Syam A.F., Tan N., Xiao Y., Liu J.-S., Lu F., Chen C.-L., Lee Y.Y., Maralit R.M., Kim Y.-S., Oshima T., Miwa H., Pang J., Siah K.T.H. |
57222222782;50162082500;36136970000;56816437200;56611839100;57222223736;57218857855;57201335892;57222224359;57222226377;7004256338;57216556340;7005966711;55451145400;8714367400;8443384400;56417185400;23500436000;57196288418;36120914800;23495616400;56191149300;57202206761;57196171210;7401663152;56921458500;57224357479;35757936600; |
Impact of the coronavirus disease 2019 pandemic on irritable bowel syndrome |
2021 |
Journal of Gastroenterology and Hepatology (Australia) |
36 |
8 |
|
2187 |
2197 |
|
4 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85101935332&doi=10.1111%2fjgh.15466&partnerID=40&md5=4f7271b5d9e13c1b4bdea5a3463fd019 |
Department of Medicine, Yong Loo Lin School of Medicine, National University Hospital, Singapore; Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Singapore Institute for Clinical Sciences, Agency for Science, Technology and Research, Singapore; Department of Clinical Psychology, James Cook University, Singapore; Division of Gastroenterology and Hepatology, Department of Medicine, National University Hospital, Singapore; Department of Medicine, Ng Teng Fong General Hospital, Singapore; Department of Otorhinolarygology, Head and Neck Surgery, Universiti Putra Malaysia, Seri Kembangan, Malaysia; Department of Anaesthesiology, Columbia Asia Hospital, Miri, Sarawak, Malaysia; Cambridge Paediatrics, Shatin, Hong Kong; Department of Gastroenterology, Sheikh Russel National Gastroliver Institute and Hospital, Dhaka, Bangladesh; Department of Gastroenterology, Sanjay Gandhi Postgraduate Institute Medical Science, Lucknow, India; Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong; State Key Laboratory of Pharmaceutical Biotechnology, The University of Hong Kong, Hong Kong; Department of Medicine, The University of Hong Kong, Hong Kong; Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, University of Indonesia/Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Departments of Gastroenterology and Hepatology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China; Department of Gastroenterology, Wuhan Union Hospital of Huazhong University of Science and Technology, Wuhan, Hubei, China; Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China; Department of Medicine, Buddhist Tzu Chi Hospital and University School of Medicine, Hualien, Taiwan; St George and Sutherland Clinical School, University of New South Wales, Sydney, NSW, Australia; Gut Research Group, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia; The Medical City, Metro Manila, Philippines; Wonkwang Digestive Disease Research Institute, Gut and Food Healthcare, Wonkwang University School of Medicine, Iksan, South Korea; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan; Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore; Centre for Infectious Disease Epidemiology and Research, National University of Singapore, Singapore |
Quek, S.X.Z., Department of Medicine, Yong Loo Lin School of Medicine, National University Hospital, Singapore; Loo, E.X.L., Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore Institute for Clinical Sciences, Agency for Science, Technology and Research, Singapore; Demutska, A., Department of Clinical Psychology, James Cook University, Singapore; Chua, C.E., Department of Medicine, Yong Loo Lin School of Medicine, National University Hospital, Singapore; Kew, G.S., Department of Medicine, Yong Loo Lin School of Medicine, National University Hospital, Singapore, Division of Gastroenterology and Hepatology, Department of Medicine, National University Hospital, Singapore; Wong, S., Department of Medicine, Ng Teng Fong General Hospital, Singapore; Lau, H.X., Singapore Institute for Clinical Sciences, Agency for Science, Technology and Research, Singapore; Low, E.X.S., Department of Medicine, Ng Teng Fong General Hospital, Singapore; Loh, T.L., Department of Otorhinolarygology, Head and Neck Surgery, Universiti Putra Malaysia, Seri Kembangan, Malaysia; Lung, O.S., Department of Anaesthesiology, Columbia Asia Hospital, Miri, Sarawak, Malaysia; Hung, E.C.W., Cambridge Paediatrics, Shatin, Hong Kong; Rahman, M.M., Department of Gastroenterology, Sheikh Russel National Gastroliver Institute and Hospital, Dhaka, Bangladesh; Ghoshal, U.C., Department of Gastroenterology, Sanjay Gandhi Postgraduate Institute Medical Science, Lucknow, India; Wong, S.H., Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong; Cheung, C.K.Y., State Key Laboratory of Pharmaceutical Biotechnology, The University of Hong Kong, Hong Kong, Department of Medicine, The University of Hong Kong, Hong Kong; Syam, A.F., Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, University of Indonesia/Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Tan, N., Departments of Gastroenterology and Hepatology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China; Xiao, Y., Departments of Gastroenterology and Hepatology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China; Liu, J.-S., Department of Gastroenterology, Wuhan Union Hospital of Huazhong University of Science and Technology, Wuhan, Hubei, China; Lu, F., Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China; Chen, C.-L., Department of Medicine, Buddhist Tzu Chi Hospital and University School of Medicine, Hualien, Taiwan; Lee, Y.Y., St George and Sutherland Clinical School, University of New South Wales, Sydney, NSW, Australia, Gut Research Group, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia; Maralit, R.M., The Medical City, Metro Manila, Philippines; Kim, Y.-S., Wonkwang Digestive Disease Research Institute, Gut and Food Healthcare, Wonkwang University School of Medicine, Iksan, South Korea; Oshima, T., Division of Gastroenterology and Hepatology, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan; Miwa, H., Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore; Pang, J., Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore, Centre for Infectious Disease Epidemiology and Research, National University of Singapore, Singapore; Siah, K.T.H., Department of Medicine, Yong Loo Lin School of Medicine, National University Hospital, Singapore, Division of Gastroenterology and Hepatology, Department of Medicine, National University Hospital, Singapore |
Background and Aim: Gastrointestinal manifestations of the coronavirus disease 2019 (COVID-19) pandemic may mimic irritable bowel syndrome (IBS), and social distancing measures may affect IBS patients negatively. We aimed to study the impact of COVID-19 on respondents with self-reported IBS. Methods: We conducted an anonymized survey from May to June 2020 in 33 countries. Knowledge, attitudes, and practices on personal hygiene and social distancing as well as psychological impact of COVID-19 were assessed. Statistical analysis was performed to determine differences in well-being and compliance to social distancing measures between respondents with and without self-reported IBS. Factors associated with improvement or worsening of IBS symptoms were evaluated. Results: Out of 2704 respondents, 2024 (74.9%) did not have IBS, 305 (11.3%) had self-reported IBS, and 374 (13.8%) did not know what IBS was. Self-reported IBS respondents reported significantly worse emotional, social, and psychological well-being compared with non-IBS respondents and were less compliant to social distancing measures (28.2% vs 35.3%, P = 0.029); 61.6% reported no change, 26.6% reported improvement, and 11.8% reported worsening IBS symptoms. Higher proportion of respondents with no change in IBS symptoms were willing to practice social distancing indefinitely versus those who deteriorated (74.9% vs 51.4%, P = 0.016). In multivariate analysis, willingness to continue social distancing for another 2–3 weeks (vs longer period) was significantly associated with higher odds of worsening IBS. Conclusion: Our study showed that self-reported IBS respondents had worse well-being and compliance to social distancing measures than non-IBS respondents. Future research will focus on occupational stress and dietary changes during COVID-19 that may influence IBS. © 2021 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd |
COVID-19; IBS; Social distancing |
adult; Article; attitude to health; clinical assessment; clinical evaluation; clinical practice; comparative study; controlled study; coronavirus disease 2019; disease severity; emotion regulation; female; general condition deterioration; health survey; human; irritable colon; major clinical study; male; pandemic; personal hygiene; psychological aspect; psychological well-being; risk factor; self report; social distancing; symptom; clinical trial; cross-sectional study; irritable colon; multicenter study; pandemic; patient compliance; questionnaire; retrospective study; self report; Singapore; Adult; COVID-19; Cross-Sectional Studies; Female; Humans; Irritable Bowel Syndrome; Male; Pandemics; Patient Compliance; Retrospective Studies; SARS-CoV-2; Self Report; Singapore; Surveys and Questio |
John Wiley and Sons Inc |
08159319 |
|
33615534 |
Article |
Q1 |
1214 |
3242 |
|
|
555 |
Susanto A.D., Winardi W., Hidayat M., Wirawan A. |
57190425587;57211654146;56435992700;57221412258; |
The use of indoor plant as an alternative strategy to improve indoor air quality in Indonesia |
2021 |
Reviews on Environmental Health |
36 |
1 |
|
95 |
99 |
|
3 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85094149752&doi=10.1515%2freveh-2020-0062&partnerID=40&md5=a7a8a53669f01afb3fc072e87f174a11 |
Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Indonesia/Persahabatan Hospital, Jl. Persahabatan Raya No.1, Jakarta, 13230, Indonesia; Department of Pulmonology and Respiratory Medicine, School of Medicine, Universitas Syiah Kuala, Banda Aceh, Indonesia; Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Mataram, Mataram, Indonesia; Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Indonesia/Persahabatan Hospital, Jakarta, Indonesia |
Susanto, A.D., Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Indonesia/Persahabatan Hospital, Jl. Persahabatan Raya No.1, Jakarta, 13230, Indonesia; Winardi, W., Department of Pulmonology and Respiratory Medicine, School of Medicine, Universitas Syiah Kuala, Banda Aceh, Indonesia; Hidayat, M., Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Mataram, Mataram, Indonesia; Wirawan, A., Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Indonesia/Persahabatan Hospital, Jakarta, Indonesia |
Indoor air pollution marked with decreased air quality below the set standard. The quality of indoor air is determined by ambient air quality as well as by a harmful substance resulting from the household activity. Indoor air pollution may cause several problems such as sick building syndrome, chronic obstructive pulmonary disease (COPD), asthma, lung cancer, and is responsible for nearly two million death in developing countries. One of the interesting research topics to overcome the indoor air pollution problem is the application of indoor plants. Although there are no established criteria to specify the best indoor plant, several studies have revealed the capability of a particular indoor plant to remove the harmful substances. This paper summarizes important information about indoor air pollution and provides the evidence-based insight of indoor plant usefulness as an alternative way for indoor air remediation. © 2021 De Gruyter. All rights reserved. |
Air pollution; Air quality; Indoor air pollution |
ecosystem restoration; human; Indonesia; indoor air pollution; plant; prevention and control; procedures; Air Pollution, Indoor; Environmental Restoration and Remediation; Humans; Indonesia; Plants |
De Gruyter Open Ltd |
00487554 |
|
32920542 |
Review |
Q2 |
644 |
7826 |
|
|
923 |
Hidayati E.L., Utami M.D., Rohsiswatmo R., Tridjaja B. |
57200542624;57217291921;55533574600;6504507193; |
Cystatin C compared to serum creatinine as a marker of acute kidney injury in critically ill neonates |
2021 |
Pediatric Nephrology |
36 |
1 |
|
181 |
186 |
|
3 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85087002032&doi=10.1007%2fs00467-020-04668-3&partnerID=40&md5=45ca525dfa7a5bd6f6f0c1d995fe7930 |
Department of Child Health, Faculty of Medicine Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia |
Hidayati, E.L., Department of Child Health, Faculty of Medicine Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Utami, M.D., Department of Child Health, Faculty of Medicine Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Rohsiswatmo, R., Department of Child Health, Faculty of Medicine Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Tridjaja, B., Department of Child Health, Faculty of Medicine Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia |
Background: Acute kidney injury (AKI) is one of the most common causes of neonatal morbidity and mortality. Diagnosing AKI in neonates is challenging as it lacks specific signs, symptoms, and biomarkers. However, detecting AKI in critically ill neonates is crucial to determine appropriate management and prevent complications. Cystatin C (CysC) has been recognized as a superior kidney biomarker reflecting kidney function in neonates. The objective of this study is to evaluate the diagnostic value of CysC as an AKI biomarker in critically ill neonates. Methods: We performed a diagnostic test between cystatin C-based estimated glomerular filtration rate (eGFR-CysC) and serum creatinine-based estimated glomerular filtration rate (eGFR-SCr) as the gold standard to diagnose AKI in 135 critically ill neonates treated in Cipto Mangunkusumo National Hospital from July 2017 to January 2018. Results: Prevalence of AKI was 23.7% predominantly in neonates with a very preterm gestational age, low birthweight, probable sepsis, and those receiving invasive oxygen therapy or nephrotoxic drugs. The proportion of AKI based on neonate RIFLE criteria was 72.7% risk, 18.9% injury, and 9% failure. eGFR-CysC had the following parameters: sensitivity, 84.8%; specificity, 61.8%; PPV, 41.8%; NPV, 89.7%; LR(+), 2.2; LR(−), 0.24; and accuracy, 67.4%. The AUROC for CysC was 84.9%. The optimal cut-off value for CysC was 1.605 mg/l. Conclusions: CysC may be used as a screening biomarker of AKI in critically ill neonates; yet, it was not superior to serum creatinine. [Figure not available: see fulltext.]. © 2020, IPNA. |
Acute kidney injury; Critically ill neonates; Cystatin C; Serum creatinine |
creatinine; cystatin C; biological marker; creatinine; cystatin C; epidermal growth factor receptor; acute kidney failure; area under the curve; Article; controlled study; creatinine blood level; critically ill patient; diagnostic accuracy; diagnostic test; diagnostic test accuracy study; diagnostic value; estimated glomerular filtration rate; extremely low birth weight; female; gestational age; human; low birth weight; major clinical study; male; negative likelihood ratio; newborn; oxygen therapy; positive likelihood ratio; predictive value; prematurity; prevalence; priority journal; receiver operating characteristic; sensitivity and specificity; sepsis; very low birth weight; acute kidney failure; critical illness; prospective study; Acute Kidney Injury; Biomarkers; Creatinine; Critical |
Springer Science and Business Media Deutschland GmbH |
0931041X |
|
32594242 |
Article |
Q1 |
831 |
5739 |
|
|